Trial Search Results

Specific Carbohydrate Diet as Maintenance Therapy in Crohn's Disease

This study investigates whether the specific carbohydrate diet (SCD) can maintain clinical remission in pediatric and adult patients with Crohn's disease.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Stanford Investigator(s):

Eligibility


Inclusion Criteria:

   - Adult or pediatric patients presenting with a new diagnosis or flare of existing
   Crohn's disease based on standard diagnostic criteria including: clinical symptoms,
   laboratory parameters, disease activity indices (Pediatric Crohn's Disease Activity
   Index (PCDAI) for patients <19years and Crohn's Disease Activity Index (CDAI) for
   patients >19years), pathology from upper endoscopy/colonoscopy and imaging studies.

Exclusion Criteria:)

   - Pregnancy

   - Other autoimmune conditions including celiac disease, rheumatoid arthritis, multiple
   sclerosis

   - Otherwise immunosuppressed patients including HIV and prior organ transplant

   - Patients diagnosed with ulcerative colitis or indeterminate colitis

   - Active tuberculosis

Ages Eligible for Study

N/A - 30 Years

Genders Eligible for Study

All

Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Ken Cox, MD
(650) 721-2250
Not Recruiting